Previously unachievable drug discovery insights created by Cardea's BPU platform
SAN DIEGO, Jan. 10, 2023 /PRNewswire/ -- Today, Cardea Bio, Inc. reaches an 8-year milestone of the first external partner starting to use the BPU...
Stay updated with breaking news from Biosignal Processing Unit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN DIEGO, Jan. 10, 2023 /PRNewswire/ -- Today, Cardea Bio, Inc. reaches an 8-year milestone of the first external partner starting to use the BPU...
In this article, graphene's potential as a commercially viable solution for lab-on-a-chip (LOC) devices is explored.
/PRNewswire/ -- MITO® Material Solutions and Cardea Bio, Inc. are pleased to announce significant progress in the international efforts to standardize graphene...
/PRNewswire/ -- Today the Graphene Council and Cardea published an interview of their work on defining the standards for using graphene in electronics and...
/PRNewswire/ -- Since its founding in late 2013, Cardea's scientists have been pioneering the development of the world's first mass produced biocompatible...